72526-105 : Erzofri Extended-release 39 mg/.25ml Intramuscular Injection


NDC72526-105
Labeler: Shandong Luye Pharmaceutical Co., Ltd.
Product Type: Human Prescription Drug
Drug Name: Erzofri Extended-release
Dosage Form: Intramuscular Injection
Application #: NDA216352
Rev. Date: 


NDC Package Codes:

  • 72526-105-11: 1 SYRINGE, GLASS IN 1 KIT (72526‑105‑11) / .25 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Paliperidone Palmitate

Dosage Strength:

  • 39 mg/.25mL

Pharmaceutical Classes:

  • Atypical Antipsychotic [EPC]

Related Products:

Based on records with the same trade name.
  • 72526-106 Erzofri Extended-release 78 mg/.5ml Intramuscular Injection by Shandong Luye Pharmaceutical Co., Ltd.
  • 72526-107 Erzofri Extended-release 117 mg/.75ml Intramuscular Injection by Shandong Luye Pharmaceutical Co., Ltd.
  • 72526-108 Erzofri Extended-release 156 mg/ml Intramuscular Injection by Shandong Luye Pharmaceutical Co., Ltd.
  • 72526-109 Erzofri Extended-release 234 mg/1.5ml Intramuscular Injection by Shandong Luye Pharmaceutical Co., Ltd.
  • 72526-110 Erzofri Extended-release 351 mg/2.25ml Intramuscular Injection by Shandong Luye Pharmaceutical Co., Ltd.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 72526-105 QR Code

< Prev: 72526-104Next: 72526-106 >

Related Discussions:

Paliperidone Palmitate
Does IM injection Paliperidone Palmitate (Invega Sustenna) lose potency or become unsafe if it has been stored in far ab... 2 replies
Paliperidone withdrawal. Will the receptors be unblocked?
I've been taking the Xeplion (Paliperidone) injection for about a year now. This drug blocks the serotonin and dopam...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.